Consolidated Statements Of Cash Flows (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Cash Flow From Operating Activities:
Net loss	$ (52,878)	$ (30,507)
Adjustments to reconcile net loss applicable to common shares to net cash used in operating activities:
Gain on sale of land	(2,081)	5,634
Gain on sale of income producing properties	3,238	139
Depreciation and amortization	12,981	14,491
Provision on impairment of notes receivable and real estate assets	31,503
Amortization of deferred borrowing costs	1,767	1,074
Earnings from unconsolidated subsidiaries and investees	128	(112)
(Increase) decrease in assets:
Accrued interest receivable	28	(128)
Other assets	(964)	7,333
Prepaid expense	2,176	52
Escrow	10,546	8,664
Earnest money	(75)	315
Rent receivables	647	(2,356)
Increase (decrease) in liabilities:
Accrued interest payable	4,045	624
Affiliate payables	(13,377)	(893)
Other liabilities	(10,432)	(8,836)
Net cash used in operating activities	(13,004)	(4,282)
Cash Flow From Investing Activities:
Proceeds from notes receivable	12,109	1,438
Originations or advances on notes receivable	(986)
Acquisition of land held for development		(2,259)
Acquisition of income producing properties	(13,002)
Proceeds from sale of income producing properties	60,852	30,043
Proceeds from sale of land	78,757	12,325
Proceeds from sale of investment in unconsolidated real estate entities	(9)
Proceeds from sale of investments	554
Investment in unconsolidated real estate entities	279	213
Improvement of land held for development	(1,101)	(1,319)
Improvement of income producing properties	(340)	(1,185)
Acquisition of non-controlling interest
Sales of controlling interest	1,980
Construction and development of new properties	(30,298)	(10,294)
Net cash provided by investing activities	108,795	28,962
Cash Flow From Financing Activities:
Proceeds from notes payable	102,534	93,753
Recurring amortization of principal on notes payable	(7,764)	(5,974)
Payments on or debt assumed on maturing notes payable	(195,386)	(110,607)
Deferred financing costs	(353)	(2,627)
Distributions to non-controlling interests	7
Common stock issuance	1,530
Net cash used in financing activities	(99,983)	(25,982)
Net decrease in cash and cash equivalents	(4,192)	(1,302)
Cash and cash equivalents, beginning of period	11,259	5,665
Cash and cash equivalents, end of period	7,067	4,363
Supplemental disclosures of cash flow information:
Cash paid for interest	26,023	32,240
Cash received for income taxes, net of payments		(48)
Series C Preferred Stock [Member]
Cash Flow From Financing Activities:
Preferred stock dividends	(105)	(105)
Series D Preferred Stock [Member]
Cash Flow From Financing Activities:
Preferred stock dividends	$ (446)	$ (422)